Advertisement
Screener

AGIOS PHARMACEUTICALS, INC. (AGIO) ROE

AGIOS PHARMACEUTICALS, INC. (AGIO) ROE

  • 2026-06-30: ROE -40.09%.
  • 2026-03-31: ROE -38.10%.
  • 2025-12-31: ROE -34.60%.
  • 2025-09-30: ROE -31.24%.

Complete source-backed roe history.

Available history
2011-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-40.09%
2026-03-31-38.10%
2025-12-31-34.60%
2025-09-30-31.24%
2025-06-3047.47%
2025-03-3145.41%
2024-12-3143.72%
2024-09-3041.45%
2024-06-30-55.25%
2024-03-31-47.40%
2023-12-31-43.41%
2023-09-30-24.76%
2023-06-30-21.78%
2023-03-31-21.04%
2022-12-31-21.06%
2022-09-30-34.56%
2022-06-30-32.91%
2022-03-31-30.18%
2021-12-31124.21%
2021-09-30114.84%
2021-06-3092.43%
2021-03-3169.11%
2020-12-31-81.94%
2020-09-30-69.11%
2020-06-30-60.75%
2020-03-31-57.36%
2019-12-31-64.24%
2019-09-30-89.43%
2019-06-30-73.10%
2019-03-31-56.15%
2018-12-31-50.33%
2018-09-30-45.06%
2018-06-30-39.48%
2018-03-31-39.20%
2017-12-31-83.80%
2017-09-30-62.89%
2017-06-30-52.76%
2017-03-31-78.55%
2016-12-31-55.35%
2016-09-30-45.49%
2016-06-30-55.36%
2016-03-31-40.91%
2015-12-31-34.11%
2015-09-30-27.62%
2015-06-30-14.80%
2015-03-31-10.83%
2014-12-31-12.61%
2014-09-30-18.88%
2014-06-30-26.98%
2014-03-31-36.61%
2013-12-31-29.97%
2013-09-30-22.68%
2013-06-3029.65%

Annual ROE

DateROE
2025-12-31-34.60%
2024-12-3143.72%
2023-12-31-43.41%
2022-12-31-21.06%
2021-12-31124.21%
2020-12-31-81.94%
2019-12-31-64.24%
2018-12-31-50.33%
2017-12-31-83.80%
2016-12-31-55.35%
2015-12-31-34.11%
2014-12-31-12.61%
2013-12-31-29.97%
2012-12-3127.91%
2011-12-3144.91%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Zymeworks Inc. (ZYME)United States$1.902B-12.44
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Generate Biomedicines, Inc. (GENB)United States$2.052B
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55